Matrix metalloproteinase-2 and -9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
Abstract
OBJECTIVE: Dysregulation of myocardial metalloproteinases (MMPs) is now regarded as an early contributory mechanism for the initiation and progression of heart failure. Doxorubicin is a strongly cardiotoxic anticancer drug. This study investigates the effects of doxorubicin on myocardial MMP-2 and MMP-9 activation. METHODS: After pre-treatment with or without carvedilol or dexrazoxane, we exposed H9c2 cardiomyocytes to doxorubicin to evaluate reactive oxygen species (ROS) formation and MMP-2 and MMP-9 expression and activation. To investigate the signaling pathways leading to doxorubicin-induced MMP activation, we also examined the phosphorylation of three members of the MAPK family (ERK1/2, p38, and JNK), the effects of selective inhibitors of ERK1/2, p38, and JNK on MMP transcription and activity, the transcription of the NAD(P)H oxidase subunit Nox1, and the effects of the NAD(P)H oxidase inhibitor DPI on MMP activation. RESULTS: Doxorubicin induces a significant increase in ROS formation and a rapid increase of MMP expression and activation. Pre-treatment with carvedilol or dexrazoxane prevented these effects. We also found that p38 is the MAPK that is mainly responsible for MMP-9 activation through an NAD(P)H-independent mechanism. ERK and JNK modulate the transcription of the NAD(P)H oxidase subunit Nox1, while the JNK/ERK NAD(P)H oxidase cascade is an important pathway that mediates doxorubicin signaling to MMP-2. Inhibition of NAD(P)H oxidase attenuates the increase in MMP-2, but augments the doxorubicin-induced increase in MMP-9. CONCLUSIONS: Enhancement of MMP-2 and MMP-9 in cardiac myocytes in response to doxorubicin is mediated by the cooperation of ERK, JNK, and p38 kinase pathways, most of which are redox dependent.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Tyrosines for which the aromatic ring is closer to the surface of a protein, in which there is a neighboring negative charge, and those in hydrophobic regions are more likely to be nitrated.
“Tyrosines for which the aromatic ring is closer to the surface of a protein, in which there is a neighboring negative charge, and those in hydrophobic regions are more likely to be nitrated (66, 877).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [877]
Cites
Oxidants, oxidative stress and the biology of ageing
Finkel, T., & Holbrook, N. J. (2000) · Nature · doi:10.1038/35041687 · Cited by 9,413 · see citing works
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,905 · see citing works
Poole-Wilson, P. A., Swedberg, K., Cleland, J. G., Di Lenarda, A., Hanrath, P., Komajda, M., Lubsen, J., Lutiger, B., Metra, M., Remme, W. J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13800-7 · Cited by 1,872 · see citing works
Signal transduction from the extracellular matrix.
Juliano, R. L., & Haskill, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.3.577 · Cited by 1,683 · see citing works
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,137 · see citing works
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,123 · see citing works
Lassègue, B., Sorescu, D., Szöcs, K., Yin, Q., Akers, M., Zhang, Y., Grant, S. L., Lambeth, J. D., & Griendling, K. K. (2001) · Circulation Research · doi:10.1161/hh0901.090299 · Cited by 839 · see citing works
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-125-1-199607010-00008 · Cited by 752 · see citing works
Spinale, F. G. (2002) · Circulation Research · doi:10.1161/01.res.0000013290.12884.a3 · Cited by 726 · see citing works
Siwik, D. A., Pagano, P. J., & Colucci, W. S. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c53 · Cited by 674 · see citing works
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H. O., & Kremer, L. C. M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003917.pub4 · Cited by 553 · see citing works
Adriamycin-induced heart failure: mechanisms and modulation
Singal, P., Li, T.-M., Kumar, D., Danelisen, I., & Iliskovic, N. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007094214460 · Cited by 464 · see citing works
Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.97.17.1708 · Cited by 443 · see citing works
Grote, K., Flach, I., Luchtefeld, M., Akin, E., Holland, S. M., Drexler, H., & Schieffer, B. (2003) · Circulation Research · doi:10.1161/01.res.0000077044.60138.7c · Cited by 417 · see citing works
Differential Expression of Tissue Inhibitors of Metalloproteinases in the Failing Human Heart
Li, Y. Y., Feldman, A. M., Sun, Y., & McTiernan, C. F. (1998) · Circulation · doi:10.1161/01.cir.98.17.1728 · Cited by 372 · see citing works
Spinale, F. G., Coker, M. L., Thomas, C. V., Walker, J. D., Mukherjee, R. D., & Hebbar, L. (1998) · Circulation Research · doi:10.1161/01.res.82.4.482 · Cited by 372 · see citing works
Spallarossa, P., Garibaldi, S., Altieri, P., Fabbi, P., Manca, V., Nasti, S., Rossettin, P., Ghigliotti, G., Ballestrero, A., & Patrone, F. (2004) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2004.05.024 · Cited by 293 · see citing works
Self-citationDisruption of the myocardial extracellular matrix leads to cardiac dysfunction
Kim, H. E., Dalal, S. S., Young, E. F., Legato, M. J., Weisfeldt, M. L., & D'Armiento, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8040 · Cited by 281 · see citing works
Liang, Q. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2003.10.001 · Cited by 239 · see citing works
Yue, T.-L., Ma, X.-L., Wang, X., Romanic, A. M., Gao-lin, L., Louden, C. S., Gu, J.-L., Kumar, S., Poste, G. H., Ruffolo, R. R., Jr., et al. (1998) · Circulation Research · doi:10.1161/01.res.82.2.166 · Cited by 234 · see citing works
Oliveira, P. J., Bjork, J. A., Santos, M. S., Leino, R. L., Froberg, M. K., Moreno, A. J., & Wallace, K. B. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.005 · Cited by 227 · see citing works
Novel NAD(P)H oxidases in the cardiovascular system: Table 1
Griendling, K. K. (2004) · Heart · doi:10.1136/hrt.2003.029397 · Cited by 213 · see citing works
Kang, Y. J., Zhou, Z., Wang, G., Buridi, A., & Klein, J. B. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13690 · Cited by 207 · see citing works
Turner, N. A., Xia, F., Azhar, G., Zhang, X., Liu, L., & Wei, J. Y. (1998) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0743 · Cited by 193 · see citing works
MAPK Superfamily Plays an Important Role in Daunomycin-Induced Apoptosis of Cardiac Myocytes
Zhu, W., Zou, Y., Aikawa, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.20.2100 · Cited by 164 · see citing works
Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species
Bleeke, T., Zhang, H., Madamanchi, N. R., Patterson, C., & Faber, J. E. (2003) · Circulation Research · doi:10.1161/01.res.0000109412.80157.7d · Cited by 162 · see citing works
Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
Coker, M. L., Thomas, C. V., Clair, M. J., Hendrick, J. W., Krombach, R. S., Galis, Z. S., & Spinale, F. G. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.274.5.h1516 · Cited by 128 · see citing works
Inoue, N., Takeshita, S., Gao, D., Ishida, T., Kawashima, S., Akita, H., Tawa, R., Sakurai, H., & Yokoyama, M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00530-x · Cited by 109 · see citing works
Wang, B., CHANG, H., Lin, S., Kuan, P., & Shyu, K. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00428-0 · Cited by 109 · see citing works
Gabai, V. L., Meriin, A. B., Yaglom, J. A., Wei, J. Y., Mosser, D. D., & Sherman, M. Y. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006632200 · Cited by 104 · see citing works
Protective effects of carvedilol against doxorubicin-induced cardiomyopathy in rats
Matsui, H., Morishima, I., Numaguchi, Y., Toki, Y., Okumura, K., & Hayakawa, T. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00362-8 · Cited by 103 · see citing works
Coker, M. L., Jolly, J. R., Joffs, C., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.2.h543 · Cited by 102 · see citing works
Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure
Altieri, P., Brunelli, C., Garibaldi, S., et al. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01187.x · Cited by 99 · see citing works
Self-citationCardiac remodeling after long term norepinephrine treatment in rats
Briest, W. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00398-4 · Cited by 97 · see citing works
van de Loo, F. A. J., Bennink, M. B., Arntz, O. J., Smeets, R. L., Lubberts, E., Joosten, L. A. B., van Lent, P. L. E. M., Roo, C. J. J. C., Cuzzocrea, S., Segal, B. H., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63509-2 · Cited by 95 · see citing works
Hasinoff, B. B., Schnabl, K. L., Marusak, R. A., et al. (2003) · Cardiovascular Toxicology · doi:10.1385/ct:3:2:89 · Cited by 89 · see citing works
Doxorubicin Paradoxically Protects Cardiomyocytes against Iron-mediated Toxicity
Corna, G., Santambrogio, P., Minotti, G., & Cairo, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310106200 · Cited by 82 · see citing works
Matrix metalloproteinase activation is an early event in doxorubicin-induced cardiotoxicity
Bai, P., Mabley, J. G., Liaudet, L., Virág, L., Szabó, C., & Pacher, P. (2004) · Oncology Reports · doi:10.3892/or.11.2.505 · Cited by 74 · see citing works
Cardioprotective interventions for cancer patients receiving anthracyclines
van Dalen, E. C., Caron, H. N., Dickinson, H., & Kremer, L. C. M. (2005) · doi:10.1002/14651858.cd003917.pub2 · Cited by 70 · see citing works
Regulation of Necrosis of H9c2 Myogenic Cells upon Transient Energy Deprivation
Yaglom, J. A., Ekhterae, D., Gabai, V. L., & Sherman, M. Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306903200 · Cited by 68 · see citing works
Importance of antioxidant and antiapoptotic effects of β-receptor blockers in heart failure therapy
Kawai, K., Qin, F., Shite, J., Mao, W., Fukuoka, S., & Liang, C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00797.2003 · Cited by 67 · see citing works
Anthracycline-Induced Cardiotoxicity
Shan, K., Lincoff, A. M., & Young, J. B. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-10-199705150-00020 · Cited by 59 · see citing works
Ohtsuka, T., Hamada, M., Saeki, H., et al. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00133-4 · Cited by 27 · see citing works
Thomas, C. V., Coker, M. L., Zellner, J. L., et al. (1998) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(98)90056-2 · Cited by 24 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S., & Navik, U. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111708 · Cited by 909 · see citing works
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works
NADPH oxidases and cardiac remodelling
Nabeebaccus, A., Zhang, M., & Shah, A. M. (2011) · Heart Failure Reviews · doi:10.1007/s10741-010-9186-2 · Cited by 138 · see citing works
Doxorubicin‐Induced Cardiomyopathy in Children
Mancilla, T. R., Iskra, B., & Aune, G. J. (2019) · Comprehensive Physiology · doi:10.1002/cphy.c180017 · Cited by 108 · see citing works
- Authors
- SPALLAROSSA, P., ALTIERI, P., GARIBALDI, S., GHIGLIOTTI, G., BARISIONE, C., MANCA, V, FABBI, P., BALLESTRERO, A., BRUNELLI, C., & BARSOTTI, A.
- Affiliations
- University of Genoa (IT)
- Corresponding author
- ALTIERI, P
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-02-15
- Volume
- 69
- Issue
- 3
- Pages
- 736-745
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2153709731
- Cited by
- 182
- References
- 44
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 6 · 2023: 15 · 2022: 7 · 2021: 11 · 2020: 6 · 2019: 7 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 10 · 2014: 11 · 2013: 11 · 2012: 9
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Research (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Chemotherapy-induced cardiotoxicity and mitigation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- doxorubicin, cardiotoxicity, MMP-2, MMP-9, MAPK signaling, p38 MAPK, ERK1/2, JNK, NADPH oxidase, NOX1, reactive oxygen species, carvedilol, dexrazoxane, H9c2 cells, heart failure, redox signaling
- MeSH terms
- Carvedilol, Anthracenes, Antibiotics, Antineoplastic, Antioxidants, Carbazoles, Catecholamines, Cell Line, Doxorubicin, Enzyme Activation, Flavonoids, Humans, Imidazoles, Propanolamines, Protein-Tyrosine Kinases, Pyridines, Razoxane, Blotting, Western, NADPH Oxidases, Matrix Metalloproteinase 2, Matrix Metalloproteinase 9, Matrix Metalloproteinases, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Myocytes, Cardiac, p38 Mitogen-Activated Protein Kinases, Imidazolines, Janus Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review